Gene and cellular therapy: gc-01

Change template to: full

Gene and cellular therapy: GC-01 – GC-04

GC-01. CaCO3 nuclei as components of doxorubicin targeted delivery systems for the treatment of solid tumors

Oleg V. Galibin², Natalia N. Sudareva^1,2, Pavel V. Popryadukhin^1,2, Olga M. Suvorova¹, Alexander D. Vilesov^1,2, Alena A. Popova³, Dmitry N. Suslov³

GC-02. Optimization of genome editing conditions in hematopoietic stem cells using designer nucleases TALEN and CRISPR/Cas9

Kirill V. Lepik¹, Alyona I. Shakirova¹, Marina О. Popova¹, Vladislav S. Sergeev¹, Albert R. Muslimov¹, Boris Fehse², Alexander D. Kulagin¹

GC-03. Prospects for the use of polyelectrolyte nanocapsules in gene therapy approaches

Tatiana V. Machel^1,2,3, Anastasia S. Bukreeva³, Anna S. Rogova³, Ekaterina E. Stefanovskaya³, Oleksii O. Peltek², Mikhail A. Trofimov⁴, Yana V. Tarakanchikova^3,4, Kirill V. Lepik¹, Mikhail V. Zyuzin², Alexander S. Timin^1,3,5, Albert R. Muslimov^1,3,4

GC-04. Individual and cell-based carriers for delivery of therapeutic compounds: from design consideration to in vivo studies

Timofey E. Karpov^1,2, Albert R. Muslimov^1,2, Dmitry О. Antuganov², Yana V. Tarakanchikova^2,3, Mikhail V. Zyuzin^2,4, Alexander S. Timin^1,2,5